Huge COVID study finds remdesivir doesn’t work—FDA grants approval anyway

[pauldun170]

Huge COVID study finds remdesivir doesn’t work—FDA grants approval anyway

WHO says its massive study was clearly not included in FDA review.

arstechnica.com

In other news

For another task force member, the profits could come from the coronavirus itself. Joseph Grogan was a lobbyist for the pharmaceutical giant Gilead Sciences before he joined the Trump administration as director of the Domestic Policy Council and led the Drug Pricing and Innovation Work Group. On Wednesday, after Gilead announced that it would be starting two clinical trials of an antiviral drug that could be used to treat Covid-19, the company’s stock price surged.

Cronyism and Conflicts of Interest in Trump’s Coronavirus Task Force

Only four members of Trump’s coronavirus task force have any scientific or medical training. Some of them, however, have pharmaceutical interests.

theintercept.com

Trump has ties to drugmaker Regeneron -- and now its stock is surging | CNN Business

President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Now the drugmaker's stock is up sharply -- and questions are swirling about the president's ties to Regeneron's billionaire CEO.

www.cnn.com

2021-01-20 12:29 | Archive of HHS – About News

www.hhs.gov

 

[Grooveriding]

Not good at all.

 

[Moonbeam]

I see no problem with a mafia don for president if he makes you feel good and keeps the 1% in power. And he makes liberz mad. How about that as a bonus. Bye, I'm off to see somebody about enlarging my cock.

 

[Brainonska511]

One point I saw on Medpage today: the problem with the WHO study is varying standards of care across study sites scattered across different countries. This could easily be a confounding factor.
Remdesivir was never a silver bullet, the confounding study factors could easily swamp a signal